GlassScriptPhysician profile
Ryan J Chauffe
NPI 1376741736
$9,114.55
in general payments reported to CMS, 2019-2025
38 companies · $1,323 in 2025
The $1,323 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,828 · 2020: $420 · 2021: $729 · 2022: $1,990 · 2023: $922 · 2024: $902 · 2025: $1,323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,890 · Entertainment: $150 · Travel and Lodging: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,889.50 |
| Entertainment | $150.00 |
| Travel and Lodging | $108.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,298.68 | 2019-2025 | Impella |
| Penumbra, INC. | $1,569.56 | 2022-2025 | Penumbra System, Indigo System |
| Janssen Pharmaceuticals, INC | $607.95 | 2019-2024 | Xarelto |
| Pfizer INC. | $516.45 | 2019-2025 | |
| Boston Scientific Corporation | $446.12 | 2019-2025 | Ffr Link, Watchman Flx, General - Vascular Intervention |
| Medtronic, INC. | $437.71 | 2021-2025 | Symplicity G3, Onyx Frontier |
| Shockwave Medical, INC | $422.18 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $267.72 | 2019-2025 | |
| Abbott Laboratories | $258.04 | 2019-2024 | Xience Skypoint |
| E.R. Squibb & Sons, L.L.C. | $196.51 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $183.59 | 2019-2024 | Lifevest |
| Shimadzu Precision Instruments, INC. | $150.00 | 2023 | Trinias |
| Recor Medical INC | $149.29 | 2025 | Paradise Ultrasound Renal Denervation System |
| Kowa Pharmaceuticals America, INC. | $146.37 | 2020-2021 | |
| Asahi Intecc USA, INC. | $140.94 | 2023 | Asahi Ptca Guide Wire |
Show all 37 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Chauffe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.